Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

Completed · Not applicable

Conditions studied: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder

In brief

This is a randomized controlled trial examining the effectiveness of a pharmacy-based intervention designed to improve adherence with antipsychotic medications among patients with serious mental illness.

Key facts

Study ID

NCT00057135

Run by

US Department of Veterans Affairs

People needed

150

Starts

2002-11-01

Expected to finish

2006-09-01

Last updated by the study team

2015-04-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be adult veterans. Diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder. At least one active oral antipsychotic prescription. History of poor medication compliance.

You may not qualify if…

• Have received depot antipsychotics in the last year. Have supervised medication administration. Have not attended a VA outpatient appointment in the past 6 months, and none are scheduled,. Are prescribed Clozapine. Have a fatal illness with a life expectancy less than 2 years.

Where it is running

• VA San Diego Healthcare System, San Diego, CA — San Diego, California, United States
• Edward Hines Jr. VA Hospital, Hines, IL — Hines, Illinois, United States
• East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ — East Orange, Massachusetts, United States
• VA Ann Arbor Healthcare System, Ann Arbor, MI — Ann Arbor, Michigan, United States
• John D. Dingell VA Medical Center, Detroit, MI — Detroit, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.